SSPL Securities Private Limited

Thursday 03 Jul, 2025 11:24 AM

PNB records 12% YoY growth in domestic deposits in Q1 Volumes soar at FSN E-Commerce Ventures Ltd counter Alembic Pharma inks deal to acquire Utility Therapeutics for $12 million DMart revenue jumps 16% YoY in Q1 FY26 Indogulf Cropsciences is flat on debut Sheela Foam CEO Nilesh Sevabrata Mazumdar resigns due to personal reasons Indian Bank's total deposits climb 9% YoY to Rs 7.44 lakh crore in Q1 RVNL appoints Chandan Kumar Verma as CFO Biocon's biologics arm gets regulatory approval in EU for Denosumab biosimilars GMR Airports Ltd Spurts 1.64% Waaree Renewable bags EPC order from domestic entity Bharat Forge gains after acquiring AAM India manufacturing NBCC (India) secures Rs 355 crore PMC contract for Gorewada Zoo Project Jindal Worldwide Ltd leads losers in 'A' group Sigachi Industries Ltd leads losers in 'B' group

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

Strides Pharma says flagship Bangalore facility gets EIR from USFDA

26-Mar-20 13:08 Hrs IST

Strides Pharma Science's flagship facility, KRS Gardens in Bangalore, Karnataka which was inspected by the United States Food & Drug Administration (USFDA) in March 2020, has received the Establishment Inspection Report (EIR), thereby confirming the successful closure of the inspections. The announcement was made before market hours today, 26 March 2020.

On a consolidated basis, the drug maker's net profit slumped 68% to Rs 93.89 crore despite a 28.5% rise in net sales to Rs 732.44 crore in Q3 December 2019 over Q3 December 2018.

Strides Pharma Science is a global pharmaceutical company. It focuses on difficult to manufacture products that are sold in over 100 countries.

The scrip was down 0.75% at Rs 317.25. It was trading in the range of Rs 312 to Rs 346.20 so far.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 42378815

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)